Directorate General of Drug Administration (DGDA)

The Directorate General of Drug Administration (DGDA) is Bangladesh's national regulatory authority for medicines and medical devices under the Ministry of Health and Family Welfare. Companies placing devices on the Bangladesh market interact with DGDA for establishment licensing, product registration, import controls, and post-market compliance.

What does DGDA regulate?

DGDA regulates medical devices and in vitro diagnostics as well as pharmaceuticals. For devices, its work includes reviewing registration applications, licensing relevant establishments, controlling imports, inspecting regulated businesses, and monitoring products after they reach the market. The Medical Devices Registration Guidelines describe the core framework used for classification and submissions.

How are medical devices classified in Bangladesh?

Bangladesh uses Classes A, B, C, and D, from lower to higher risk. Classification is based on intended purpose and risk rules, not simply the product name. Class A products may follow lighter controls, while Classes B, C, and D generally require product registration before commercial supply. Sterility, measuring functions, invasiveness, duration of contact, and whether a product is an IVD can change the applicable rule.

Does Bangladesh require a local authorized representative?

An overseas manufacturer generally needs a locally established and appropriately licensed representative or importer to interact with DGDA and place products on the market. The local party is important for the application, importation, authority correspondence, complaints, vigilance, and recalls. Manufacturers should define access to the registration and responsibilities for changes or termination in writing.

What documents are commonly needed for DGDA registration?

The dossier usually includes an application, device description and intended use, classification rationale, manufacturer and local-party information, quality-management evidence such as ISO 13485, labeling and instructions for use, safety and performance evidence, and proof of authorization or market history where applicable. Higher-risk products require more detailed evidence. Exact forms and legalization expectations should be checked against the current DGDA guidance.

Does DGDA registration cover post-market duties?

Registration is only one stage. The manufacturer and local responsible parties must maintain compliant labeling and distribution records, manage complaints and adverse events, report relevant changes, and cooperate with corrective actions or recalls. Renewals and license maintenance should be tracked before expiry.

Where can I find official DGDA information?

Use the DGDA official website and its published medical device guidance for current forms, notices, and contacts. Confirm live fees and submission procedures before filing because administrative requirements can change.

Related Bangladesh regulatory topics

See our Bangladesh medical device registration overview for a practical market-entry summary.